Type 2 diabetes has tremendous Macroeconomic impact due to the high cost of treating the chronic illness and its many related morbidities, such as amputation, kidney failure and blindness.
https://www.diabetes.org/about-us/statistics/cost-diabetes
The total estimated 2017 cost of diagnosed diabetes of $327 billion includes $237 billion in direct medical costs and $90 billion in reduced productivity.
A very large longitudinal study (n = 50,152) showed that seniors with pre-diabetes progress to full-blown Type 2 diabetes at a rate of about 5% per year but higher for those with severe obesity (BMI of 40 or higher), hypertension, a higher blood sugar level and/ or a family history of diabetes.
During the study period, regression to a normal blood sugar level or death happened more often than progression to diabetes. The U.S Preventive Services Task Force recognizes that there are effective ways to reverse pre-diabetes to a normal, healthy blood sugar level. They recommend that primary care doctors discuss this with their patients with pre-diabetes.
https://www.medpagetoday.com/endocrinology/diabetes/98302?xi…
The US obesity prevalence was 42.4% in 2017 – 2018. (BMI > 30)
From 1999 –2000 through 2017 –2018, US obesity prevalence increased from 30.5% to 42.4%. During the same time, the prevalence of severe obesity increased from 4.7% to 9.2%. (BMI > 40)
https://www.cdc.gov/obesity/data/adult.html
For children and adolescents aged 2-19 years in 2017-2018, the prevalence of obesity was 19.3%.
https://www.cdc.gov/obesity/data/childhood.html
I and other METARs have reversed pre-diabetes by a lower-carb diet and exercise.
The rate of Type 2 diabetes will probably rise over the next couple of decades as pre-diabetic seniors age. Also, the young obese will develop Type 2 diabetes at a younger age than the current generation, which had a lower rate of youth obesity. The companies providing monitoring devices will benefit.
https://meticulousblog.org/top-10-companies-in-diabetes-care…
Wendy